made similar observations and demonstrated that variations in gut microbiota composition could effectively differentiate patients diagnosed with allergic asthma (IL-4 high) from non-allergic asthma (IL-4 low) patients (Hu et al., 2023). This evidence concerns the gene IL4 and allergic asthma.